Overview
Fixed subaortic stenosis, also known as discrete subaortic stenosis (DSS) or subvalvular aortic stenosis, is a congenital heart defect in which there is a fixed obstruction to blood flow just below the aortic valve in the left ventricular outflow tract (LVOT). The obstruction is most commonly caused by a fibrous or fibromuscular membrane (ridge) that encircles the outflow tract beneath the aortic valve, though in some cases a more tunnel-like narrowing may be present. This condition primarily affects the cardiovascular system by creating a pressure gradient between the left ventricle and the aorta, forcing the heart to work harder to pump blood to the body. Over time, the turbulent blood flow caused by the obstruction can damage the aortic valve leaflets, leading to progressive aortic regurgitation (leaking of the aortic valve). Key symptoms may include exercise intolerance, shortness of breath, chest pain, dizziness, fainting (syncope), and heart murmur detected on physical examination. Some patients may be asymptomatic in early life, with the condition discovered incidentally during evaluation of a heart murmur. Left ventricular hypertrophy (thickening of the heart muscle) develops as the heart compensates for the increased workload. Fixed subaortic stenosis can occur as an isolated defect or in association with other congenital heart malformations such as ventricular septal defect, coarctation of the aorta, or atrioventricular canal defect. It may also be seen in the context of Shone complex. The primary treatment for significant fixed subaortic stenosis is surgical resection of the obstructing membrane or fibromuscular tissue, often combined with septal myectomy to reduce the risk of recurrence. Surgery is generally recommended when the pressure gradient across the obstruction becomes hemodynamically significant (typically a peak gradient exceeding 30-50 mmHg) or when progressive aortic regurgitation develops. Recurrence of the obstruction after surgical resection occurs in a notable proportion of patients, necessitating long-term follow-up and potentially repeat surgery. Medical management alone is generally not effective in relieving the obstruction but may be used to manage symptoms. Endocarditis prophylaxis may be recommended in certain clinical scenarios. Regular echocardiographic surveillance is essential for monitoring progression and detecting recurrence after surgery.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Fixed subaortic stenosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Fixed subaortic stenosis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Fixed subaortic stenosis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Fixed subaortic stenosis.
Community
No community posts yet. Be the first to share your experience with Fixed subaortic stenosis.
Start the conversation →Latest news about Fixed subaortic stenosis
No recent news articles for Fixed subaortic stenosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Fixed subaortic stenosis
What is Fixed subaortic stenosis?
Fixed subaortic stenosis, also known as discrete subaortic stenosis (DSS) or subvalvular aortic stenosis, is a congenital heart defect in which there is a fixed obstruction to blood flow just below the aortic valve in the left ventricular outflow tract (LVOT). The obstruction is most commonly caused by a fibrous or fibromuscular membrane (ridge) that encircles the outflow tract beneath the aortic valve, though in some cases a more tunnel-like narrowing may be present. This condition primarily affects the cardiovascular system by creating a pressure gradient between the left ventricle and the a
At what age does Fixed subaortic stenosis typically begin?
Typical onset of Fixed subaortic stenosis is childhood. Age of onset can vary across affected individuals.